Skip to main content

Montelukast News

FDA Medwatch Alert: Singulair (montelukast) and All Montelukast Generics: Strengthened Boxed Warning - Due to Restricting Use for Allergic Rhinitis

ISSUE: FDA is strengthening existing warnings about serious behavior and mood-related changes with montelukast (Singulair and generics), which is a prescription medicine for asthma and allergy. FDA...

FDA Medwatch Alert: FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast

March 4, 2020 - The U.S. Food and Drug Administration today announced that it is requiring a boxed warning – the agency’s most prominent warning – for montelukast (sold under the brand name Singulair ...

FDA Medwatch Alert: FDA announces voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles

The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Hay Fever, Allergic Rhinitis, Chronic Obstructive Pulmonary Disease, Allergies, Asthma - Maintenance, Asthma

Related drug support groups

Singulair

Montelukast patient information at Drugs.com